ROBO1 Silencing via Lentiviral shRNA
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Brigham and Women's Hospital, Mayo Clinic, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Kumamoto University Hospital, Dana-Farber Cancer Institute, University of Massachusetts Lowell, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Instytut Hematologii i Transfuzjologi
Variable analysis
- ROBO1 silencing using shRNA constructs (shRNA4 and shRNA5)
- ROBO1 knockdown efficiency (confirmed by western blotting)
- Apoptosis (assessed by flow cytometry for annexin V-propidium iodide staining)
- Scrambled-transfected cells (used as controls for procedure-related toxicity)
- Positive control: Not mentioned
- Negative control: Scrambled-transfected cells
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!